MAPK15 and lung adenocarcinoma: More recently, we clarify that MAPK15 interacts with NF-κB p50 and enters the nucleus, in which NF-κB p50 binds to the EP3 promoter and transcriptionally regulates the expression of EP3, thereby affecting the migration of lung adenocarcinoma [13].